Jane Street Group, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.34 - $0.74 $374 - $815	1,102 Added 5.88%	19,834 $6,000
Q1 2024 May 15, 2024	BUY	$0.28 - $0.66 $5,244 - $12,363	18,732 New	18,732 $10,000
Q3 2023 Nov 14, 2023	BUY	$0.2 - $2.08 $6,112 - $63,571	30,563 New	30,563 $6,000
Q4 2022 Feb 14, 2023	BUY	$1.37 - $4.42 $19,253 - $62,118	14,054 New	14,054 $23,000
Q2 2022 Aug 16, 2022	SELL	$2.71 - $3.6 $1,241 - $1,648	-458 Reduced 3.65%	12,085 $33,000
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $77,326 - $103,016	-25,690 Reduced 67.19%	12,543 $48,000
Q4 2020 Feb 17, 2021	BUY	$3.99 - $17.73 $94,882 - $421,619	23,780 Added 164.53%	38,233 $173,000
Q2 2020 Aug 17, 2020	SELL	$4.42 - $12.66 $18,263 - $52,311	-4,132 Reduced 22.23%	14,453 $162,000
Q1 2020 May 15, 2020	BUY	$4.01 - $8.88 $74,525 - $165,034	18,585 New	18,585 $86,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.